It is well recognized that the cellular context contributes to susceptibility to oncogenic transformation mediated by different “driver” oncogenes. The focus of our laboratory is to discover and understand the critical genetic and epigenetic factors that determine the cellular-context-dependent oncogenesis in distinct cancer types, with a primary focus on sarcoma and melanoma. We use multimodality approaches, including transcriptome analyses, epigenome mapping, and gene-expression-based high-throughput screens, as well as murine models to understand the mechanisms of pathogenesis and to develop biomarkers and targeted therapies based on insight into disease pathogenesis.
Ping Chi, MD, PhD
Research FocusPhysician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic transcription factors in GIST and other solid tumors.
- MD, Weill Cornell Medical College
- PhD, The Rockefeller University
- Yan Z, Chi P, Bibb JA, Ryan TA, Greengard P. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol. 2002 May 1;540(Pt 3):761-70.
- Chi P, Greengard P, Ryan TA. Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron. 2003 Apr 10;38(1):69-78.
- Kimmel Scholar Award, Sidney Kimmel Foundation (2012)
- Research Grant, Sarcoma Foundation of America (2012)
- Grant, GIST Cancer Awareness Foundation (2012)
- Director’s New Innovator Award, National Institutes of Health (2012)
- Clinical Scientist Development Award, National Instistutes of Health (2011)